Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Minerva Endocrinologica
|
March 16, 2016
Medical treatment of Cushing's Disease
Daniel Cuevas-Ramos, Maria Fleseriu
Journal of Molecular Endocrinology
|
March 21, 2014
Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
Daniel Cuevas-Ramos, Maria Fleseriu
Drug Design, Development and Therapy
|
January 27, 2016
Pasireotide: a novel treatment for patients with acromegaly
Daniel Cuevas-Ramos, Maria Fleseriu
JCEM Case Reports
|
April 18, 2024
Acromegaly Type 1: A Representative Patient
Daniel Cuevas-Ramos, Shlomo Melmed
The Journal of Endocrinology
|
August 20, 2014
Treatment of Cushing's disease: a mechanistic update
Daniel Cuevas-Ramos, Maria Fleseriu
The New England Journal of Medicine
|
June 29, 2007
Images in clinical medicine. Endemic multinodular goiter
Daniel Cuevas-Ramos, Bernardo Pérez-Enríquez
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
April 17, 2007
[Subclinical thyroid dysfunction. Diagnostic and therapeutic considerations]
Daniel Cuevas-Ramos, Bernardo Pérez-Enríquez
Hormone Molecular Biology and Clinical Investigation
|
June 20, 2016
Modulation of energy balance by fibroblast growth factor 21
Daniel Cuevas-Ramos, Carlos A Aguilar-Salinas
Best Practice & Research. Clinical Endocrinology & Metabolism
|
January 21, 2021
The definition of remission and recurrence of Cushing's disease
José Miguel Hinojosa-Amaya, Daniel Cuevas-Ramos
Frontiers in Physiology
|
February 27, 2019
Fibroblast Growth Factor 21 and Browning of White Adipose Tissue
Daniel Cuevas-Ramos, R Mehta, Carlos A Aguilar-Salinas
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Minerva Endocrinologica
|
March 16, 2016
Medical treatment of Cushing's Disease
Daniel Cuevas-Ramos, Maria Fleseriu
Journal of Molecular Endocrinology
|
March 21, 2014
Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
Daniel Cuevas-Ramos, Maria Fleseriu
Drug Design, Development and Therapy
|
January 27, 2016
Pasireotide: a novel treatment for patients with acromegaly
Daniel Cuevas-Ramos, Maria Fleseriu
JCEM Case Reports
|
April 18, 2024
Acromegaly Type 1: A Representative Patient
Daniel Cuevas-Ramos, Shlomo Melmed
The Journal of Endocrinology
|
August 20, 2014
Treatment of Cushing's disease: a mechanistic update
Daniel Cuevas-Ramos, Maria Fleseriu
The New England Journal of Medicine
|
June 29, 2007
Images in clinical medicine. Endemic multinodular goiter
Daniel Cuevas-Ramos, Bernardo Pérez-Enríquez
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
April 17, 2007
[Subclinical thyroid dysfunction. Diagnostic and therapeutic considerations]
Daniel Cuevas-Ramos, Bernardo Pérez-Enríquez
Hormone Molecular Biology and Clinical Investigation
|
June 20, 2016
Modulation of energy balance by fibroblast growth factor 21
Daniel Cuevas-Ramos, Carlos A Aguilar-Salinas
Best Practice & Research. Clinical Endocrinology & Metabolism
|
January 21, 2021
The definition of remission and recurrence of Cushing's disease
José Miguel Hinojosa-Amaya, Daniel Cuevas-Ramos
Frontiers in Physiology
|
February 27, 2019
Fibroblast Growth Factor 21 and Browning of White Adipose Tissue
Daniel Cuevas-Ramos, R Mehta, Carlos A Aguilar-Salinas
Page
of 8